Authors' objectives: Psoriasis is a skin condition that causes the skin to look red and flaky, with crusty patches of skin covered with silvery scales. These patches of skin are often sore and cause itching. Common areas for psoriasis patches to occur are the elbows, knees, scalp and lower back. The treatment of psoriasis is often successful, but does not completely cure the condition. Psoriasis usually comes and goes so there are times when a patient who has psoriasis may feel well, but other times when the condition flares up and causes the patient a lot of discomfort. As psoriasis is a condition of the skin, some patients may also feel quite upset about the way their skin looks. Guselkumab is a new drug for the treatment of psoriasis which is injected under the skin. Some studies have suggested guselkumab may be safe and helpful in improving this skin condition. If guselkumab is licensed for use in the UK, it could be a new treatment option for patients with psoriasis that may work and be more convenient for patients, and cause fewer side effects than current treatments.

Project Status: Completed

Year Published: 2016

URL for published report: http://www.hsric.nihr.ac.uk/topics/guselkumab-for-moderate-to-severe-psoriasis/

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: NIHR Horizon Scanning Centre

Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269

Contact Name: c.packer@bham.ac.uk

Contact Email: c.packer@bham.ac.uk

Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)